We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Zoonotic Coronavirus Genetically Analyzed

By LabMedica International staff writers
Posted on 04 Dec 2012
A genetic analysis has been made of the novel coronavirus virus that is causing alarm among global public health authorities. More...


The results of the sequencing and analysis of this virus could be used to develop diagnostic methods and possibly in creating therapies and vaccines if they are eventually needed for this emerging disease.

Molecular virologists at the Erasmus Medical Center (Rotterdam, The Netherlands) carried out a genomic characterization of a newly discovered coronavirus, known as HCoV-EMC/2012 virus, which is associated with acute respiratory distress syndrome in humans.

The scientists used a combination of approaches, including deep sequencing, cycle sequencing on a more traditional capillary sequencer, and determination of the genomic termini by rapid amplification of complementary cDNA ends (RACE), the complete genome sequence of HCoV-EMC/2012 was determined from material that had been subjected to passage in cell culture six times.

Phylogenetic analyses place the virus within the Betacoronavirus genus, where its closest fully sequenced relatives are viruses called BtCoV-HKU4 from Tylonycteris pachypus (Lesser bamboo bats) and BtCoV-HKU5 from Pipistrellus abramus (Japanese house bat) both of which were originally isolated in Asia. The HCoV-EMC/2012 bears only 77% sequence similarity with the BtCoV-HKU5 virus, however, making it distinct enough to be called a novel species of virus. A partial sequence from a virus that was isolated from a species of bat in the Netherlands appears to be a closer match with HCoV-EMC/2012, but without a full genome sequence, the exact degree of relatedness is unknown.

Ron Fouchier, PhD, who led the study, said: "The virus is most closely related to viruses in bats found in Asia, and there are no human viruses closely related to it. Therefore, we speculate that it comes from an animal source. A well-annotated genome sequence is crucial to further the development of diagnostic methods, and antivirals and vaccines that might be needed. Considering that three cases of disease from the virus have already been identified we certainly need the diagnostics already.” The study was published on November 20, 2012, in the journal mBio.

Related Links:

Erasmus Medical Center



Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
COVID-19 Antigen Self-Test
Panbio COVID-19 Antigen Self-Test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.